Zoetis Inc. (ZTS)
| Market Cap | 96.02B |
| Revenue (ttm) | 7.41B |
| Net Income (ttm) | 1.91B |
| Shares Out | 474.80M |
| EPS (ttm) | 3.99 |
| PE Ratio | 50.69 |
| Forward PE | 38.76 |
| Dividend | $0.90 (0.45%) |
| Ex-Dividend Date | Jul 20, 2021 |
| Volume | 1,235,834 |
| Open | 201.13 |
| Previous Close | 200.39 |
| Day's Range | 200.12 - 202.80 |
| 52-Week Range | 141.02 - 210.10 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 224.58 (+11.1%) |
| Est. Earnings Date | Nov 4, 2021 |
About ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that...
Financial Performance
In 2020, Zoetis's revenue was $6.68 billion, an increase of 6.63% compared to the previous year's $6.26 billion. Earnings were $1.64 billion, an increase of 9.20%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for Zoetis stock is "Buy." The 12-month stock price forecast is 224.58, which is an increase of 11.06% from the latest price.
News
Zoetis Declares Fourth Quarter 2021 Dividend
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #dividend--The Board of Directors of Zoetis Inc. has declared a fourth quarter 2021 dividend payable to holders of the company's common stock of $0.25 per share.
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Got $1,000? 2 Super-Smart Stocks That Could Make You Richer Over the Next Decade
Here are two stocks to add to your basket of buys this fall.
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis Inc. will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 4, 2021.
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Seramount100Best2021--Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount.
COLL vs. ZTS: Which Stock Should Value Investors Buy Now?
COLL vs. ZTS: Which Stock Is the Better Value Option?
Zoetis to Participate in the Jefferies Virtual Pet Care Summit
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to present at the Jefferies Virtual Pet Care Summit on Thursday, Sept. 16th.
Final Trades: Bristol Myers, Marathon Petroleum, Zoetis & more
The "Halftime Report" traders give their top picks to watch for the second half.
7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn
These seven stocks to buy right now for a bear market are also generally strong in bull markets. Their resistance is the key element.
Zoetis, Inc Among This Week's U.S. Large Caps Stocks
Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Zoetis, Inc among others.
Zoetis CEO on Q2 results: “trends in companion animal are durable”
Zoetis Inc. (NYSE: ZTS) reported its financial results for the second quarter on Thursday that beat Wall Street estimates. The stock was largely unbothered in after-hours trading despite raised guidance...
Zoetis CEO: People are still getting pandemic pets
People are adopting more pets, spending more time with their pets and spending more money on pets, which means a sustained period of growth for pet-care company Zoetis, says Zoetis CEO Kristin Peck. Pec...
Zoetis' (ZTS) Q2 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) earnings and revenues beat estimates in the second quarter of 2021. The company raised its financial guidance for 2021.
Zoetis (ZTS) Surpasses Q2 Earnings and Revenue Estimates
Zoetis (ZTS) delivered earnings and revenue surprises of 10.19% and 6.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zoetis Announces Second Quarter 2021 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis reports second quarter 2021 results.
Why Earnings Season Could Be Great for Zoetis (ZTS)
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products
PARSIPPANY, N.J. & RUTHERFORD, Australia--(BUSINESS WIRE)---- $ZTS #acquisition--Zoetis to acquire Jurox, a leading provider and manufacturer of livestock and companion animal products.
Is a Beat in Store for Zoetis (ZTS) This Earnings Season?
Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases second-quarter 2021 results.
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Pharma/Biotech Stocks Poised to Beat on Earnings in Q2
We take a look at a few pharma/biotech companies, which are poised to beat on earnings in the second quarter.
CORT or ZTS: Which Is the Better Value Stock Right Now?
CORT vs. ZTS: Which Stock Is the Better Value Option?
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Millennials And Gen Z Are Bringing Animal Health Stocks To New Highs
A year of pandemic lockdowns yielded a year of lavish attention for pets. Animal health stocks like Zoetis and Idexx Laboratories reflected that rise in affection.